• March 1, 2016

    Jay Kasner, MD: Devoted Doctor and Mentor

    Jay was the stalwart. His patients loved him. All the staff loved him. He was a caring and skilled doctor, always even-tempered and affable, always positive, with a wonderful sense of humor almost as dry as that of his wife of 36 years, Dr Joanne Carpentier-Kasner, DVM.
  • February 29, 2016

    ACTION ALERT - Comprehensive Addiction and Recovery Act (CARA)

    This Monday at 5:30 PM (EST), the U.S. Senate will debate and vote on S. 524, the Comprehensive Addiction and Recovery Act (CARA).
  • February 23, 2016

    ASAM Applauds Appointment of Kimberly Johnson, PhD to Serve as Director of Center for Substance Abuse Treatment (CSAT) within SAMHSA

    ASAM applauds last weeks announcement that Kimberly Johnson, PhD has been appointed to serve as the next Director of the Center for Substance Abuse Treatment (CSAT) within the Substance Abuse and Mental Health Services Administration (SAMHSA).
  • January 4, 2016

    Editor's Comments

    Trends and themes: Last year marked the 100th anniversary of the enactment of the Harrison Narcotics Tax Act, which, in regulating the access to opium derivatives and later, to cocaine and other intoxicants, created many of the same policy contradictions and arguments that we encounter today. Clinicians who insisted on providing maintenance dosing of paregoric, codeine, or morphine to their dependent patients found themselves facing de-licensure and prison...
  • December 15, 2015

    Play a Role in the Future of Addiction Medicine

    The World Health Organization is requesting input from physicians, nurses, insurers, public health professionals and policy-makers on the ICD-11, the next version of the disease classification system used around the world. Of note to addiction clinicians are some reclassifications from the ICD-10 related to the relationships between impulse control disorders and behavioral addiction, such as pathological gambling, and substance use disorder.
  • December 15, 2015

    International Statement Recommending Against the Use of Terminology That Can Stigmatize People

    An editorial by Journal of Addiction Medicine Senior Editor, Dr. Richard Saitz, MPH, FACP, DFASAM, encourages the use of precise and non-stigmatizing terminology.
  • December 15, 2015

    Ask the PCSS Expert: Does Evidence Show Naltrexone Reduces Cravings?

    A physician wrote the PCSS mentor network seeking advice on naltrexone. They asked three questions.
  • December 15, 2015

    Patients with Addiction Need Treatment - Not Stigma

    We must change the conversation about what it means to have a substance use disorder, and we also must increase access to evidence-based treatments.
  • December 15, 2015

    SAMHSA Provides Guidance on 42 CFR Part 2

    Over the summer, the Substance Abuse and Mental Health Services Administration (SAMHSA) hosted a webinar series on health information technology (IT). The purpose of these webinars was for providers, consumers, states, organizations and vendors to be educated on the regulations and usage of health IT and to explore the innovative ways this technology is being used to improve the quality of care delivery, support patient engagement and self-management, improve the efficiency of the workforce and expand access to care.
  • December 15, 2015

    ASAM Leadership Series: Dr. Saitz, MPH, FACP, DFASAM

    Dr. Saitz, MPH, FACP, DFASAM, is, by all account, a funny and charming man who is also an accomplished researcher and expert in (among areas) SBIRT.
  • December 14, 2015

    President Obama Announces Efforts to Address Opioid Epidemic

    Dr. Brad Hall, DFASAM, President of the West Virginia ASAM chapter, and Penny Mills, CEO of ASAM, attended community discussion on the prescription drug abuse and heroin epidemic led by President Barack Obama in Charleston, West Virginia.
  • December 14, 2015

    Dr. Beny J. Primm: Pioneer in Research, Treatment of Addiction and Co-Occurring Disorders

    "For 50 years, ASAM member Dr. Primm had been on the front lines in the use of medication in treating opioid dependence" writes Dr. Lawrence Brown, Jr, MPH, DFASAM.
  • December 14, 2015

    Editor's Comments

    Even with MAT, e.g., agonist therapy entailing buprenorphine, there is a range of understandings about appropriate maintenance dosages, duration of therapy, and compliance testing. This may be more true of the application of psychotherapies, and reflects the wide variety of treatment settings and of skill sets among therapists.
  • December 13, 2015

    Repurposing Medications to Treat Addiction?

    If researchers can get access to test new medications that have been developed and tested in human clinical trials for other non-addiction conditions, they could be proven effective for addiction treatment.
  • December 13, 2015

    ASAM Testifies to House Subcommittee on the Use of Medication in Addiction Treatment

    Dr. Corey Waller, Chair of the Legislative Advocacy Committee, testified on behalf of ASAM at the House Energy and Commerce Subcommittee on Health for a hearing reviewing legislative proposals to combat the national drug abuse crisis.